Free Submission Public Relations &
Deutsch English

Pharmaceuticals in Indonesia: ISIC 2423

Indonesia pharmaceuticals market reported 34% of production sourced from the top five companies operating in the sector in 2012

Print article Print article
2014-02-03 10:05:04 - Pharmaceuticals in Indonesia: ISIC 2423 - a new market research report on

Indonesia´s pharmaceuticals market is fairly small but fast-growing, expanding 79% over 2007-2012. Overall, as government spends only 1% of GDP on healthcare, government spending on pharmaceutical products is not significant in total sales, represented in total by household expenditure and B2B purchases.

Imports in 2012 account for 19% of total market size and experience growth of 74% from 2007, mainly derived from China, the US, Germany, France, Switzerland. Imported pharmaceutical products are mostly medicaments, vaccines and other preparations (51% of total imports in 2012). Turnover of local producers accounts for Rp66 trillion in 2012 and increases 88% over review period, with 5% of product output exported.

Top five companies in industry account for around 34% of production, despite 94% of companies having



fewer than nine employees.

Click for report details: ..

Browse all Healthcare and Medical Market Research Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Market Research Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Mike King
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact